Asensus Surgical Inc. (ASXC) News
Filter ASXC News Items
ASXC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ASXC News Highlights
- For ASXC, its 30 day story count is now at 2.
- Over the past 16 days, the trend for ASXC's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- DEC are the most mentioned tickers in articles about ASXC.
Latest ASXC News From Around the Web
Below are the latest news stories about ASENSUS SURGICAL INC that investors may wish to consider to help them evaluate ASXC as an investment opportunity.
Asensus Announces Sale of Senhance Robotic System in RomaniaSenhance® System to be placed at a pediatric hospital in Timisoara, Romania Senhance Surgical System The Senhance Surgical System was developed to address the challenges of pediatric surgery while preserving the benefits of minimally invasive surgery. RESEARCH TRIANGLE PARK, N.C., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient, announced the sale of a Senhance® Surgical Syst |
3 Stocks at the Forefront of Medical RoboticsEvery now and then, speculation – within carefully defined limits – may be appropriate, which brings us to the case for medical robotics stocks to buy. |
Senhance Robotic System Sold by Asensus SurgicalSenhance® System to be placed at a hospital in the Commonwealth of Independent States Senhance Surgical System The Senhance Surgical System is the only commercially available robotic surgery system with haptic feedback, a differentiating feature for surgeons. RESEARCH TRIANGLE PARK, N.C., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company digitizing the interface between the surgeon and patient, announced that a Senhance® Surgical System has |
Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2023RESEARCH TRIANGLE PARK, N.C., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the third quarter 2023. Recent Highlights 17% growth in surgical procedures, with over 2,700 procedures performed globally year to date at September 30, 2023Two Senhance Surgical programs |
Asensus Surgical Announces Sale of Senhance Robotic SystemSenhance® System to be placed at a pediatric hospital in the Commonwealth of Independent States Senhance Robotic System A Senhance Surgical System will be placed in a pediatric hospital in the Commonwealth of Independent States (CIS) region. RESEARCH TRIANGLE PARK, N.C., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company digitizing the interface between the surgeon and the patient, announced that a Senhance® Surgical System was sold to the Co |
Asensus Surgical, Inc. Announces Agreement with Flex for Design and Advanced Manufacturing Services for the LUNA™ Surgical SystemRESEARCH TRIANGLE PARK, N.C., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced an agreement with diversified manufacturer Flex (NASDAQ: FLEX) for design and advanced manufacturing services for Asensus’s previously-announced LUNA Surgical System, a next-generation surgical robot platform. Flex will provide |
Asensus Surgical, Inc. Schedules Third Quarter Financial and Operating Results Conference Call for November 14, 2023RESEARCH TRIANGLE PARK, N.C., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient announced today that it plans to release 2023 third quarter financial and operating results after the market closes on Tuesday, November 14, 2023. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same day. The call will be concurrently webcast. To lis |
Asensus Surgical Announces Klinikum Idar-Oberstein Hospital in Germany to Initiate Senhance Surgery ProgramExpanding Minimally Invasive Surgery in Germany Senhance Surgical System The Senhance Surgical System is designed to increase surgeon control and reduce variability through Augmented Intelligence and deep learning capabilities. RESEARCH TRIANGLE PARK, N.C., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, announced that Klinikum Idar-Oberstein Hospital located in Germany, |
Why Did AMC Stock Just Hit a Record Low?AMC Entertainment (AMC) stock just hit a new low on Thursday as the movie theater company continues to step on investors' toes. |
Why Is Asensus Surgical (ASXC) Stock Up 18% Today?Asensus Surgical (ASXC) stock is rising higher on Thursday as investors react to news of a collaboration with Nvidia NVDA). |